Phase 1 study of ABI-009 (nab-rapamycin) for surgically refractory epilepsy (RaSuRE). - Hall K; Saneto R; Randle S; Wainwright MS; Berry P; Leary S; Mirzaa G; Lockrow J; Goldstein H; Ojemann J; Thiessen R; Willis H; et al. (Epilepsia, 2025)